156 related articles for article (PubMed ID: 15669586)
1. S-phase fraction in superficial urothelial carcinoma of the bladder--a prospective, long-term, follow-up study.
Falkman K; Tribukait B; Nyman CR; Larsson P; Norming U
Scand J Urol Nephrol; 2004; 38(4):278-84. PubMed ID: 15669586
[TBL] [Abstract][Full Text] [Related]
2. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
4. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
6. Significance of random bladder biopsies in superficial bladder cancer.
May F; Treiber U; Hartung R; Schwaibold H
Eur Urol; 2003 Jul; 44(1):47-50. PubMed ID: 12814674
[TBL] [Abstract][Full Text] [Related]
7. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group.
Liukkonen T; Rajala P; Raitanen M; Rintala E; Kaasinen E; Lipponen P
Eur Urol; 1999 Nov; 36(5):393-400. PubMed ID: 10516448
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.
Larsson P; Wijkström H; Thorstenson A; Adolfsson J; Norming U; Wiklund P; Onelöv E; Steineck G
Scand J Urol Nephrol; 2003; 37(3):195-201. PubMed ID: 12775276
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder.
Norming U; Tribukait B; Nyman CR; Nilsson B; Wang N
J Urol; 1992 Nov; 148(5):1420-6; discussion 1426-7. PubMed ID: 1433541
[TBL] [Abstract][Full Text] [Related]
13. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
15. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
Shariat SF; Weizer AZ; Green A; Laucirica R; Frolov A; Wheeler TM; Lerner SP
Urology; 2000 Nov; 56(5):735-40. PubMed ID: 11068290
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study.
Tachibana M; Miyakawa A; Miyakawa M; Saito S; Nakamura K; Baba S; Murai M
Cancer Detect Prev; 1999; 23(2):155-62. PubMed ID: 10101597
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
Lee SE; Park MS
Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
